Meritocracy, transparency and forward-thinking
The values that guide Fondazione Dompé each day are meritocracy, transparency and forward-thinking. The Statutory Bodies define the scope of the activities and ensure compliance with regulations. The Scientific Committee is responsible for the allocation of funds, along with the evaluation and selection criteria applying to scholarships and grants.Download the Bylaws
Sergio Dompé is an entrepreneur in the pharmaceutical and biotechnological industries and President of Dompé, the pharmaceutical group that develops innovative therapeutic solutions for rare diseases.
With honorary doctorates in Biotechnology, specializing in pharmaceutics (Bologna, 1996), Medical Biotechnology (L’Aquila, 2005) and Pharmacy (Urbino, 2010), Sergio Dompé has been one of the first entrepreneurs in Italy to grasp the true potential of biotechnology applied to human health. He has also developed an extensive network of partnerships in Dompé’s main therapeutic fields with other leading research centres into diseases.
In 2017, Sergio Dompé funded and established Movendo Technology, developed in conjunction with the Italian Institute of Technology. The company designs and produces innovative robotic technologies for rehabilitation. In 2004 his innovation and entrepreneurship were rewarded with the "La Lombardia per il lavoro" award. In 2016, he received the "Foundation Aiuto per la Ricerca sulle Malattie Rare" award, in recognition of his research work and in 2017 he was awarded the "Guido Carli" award. Since 2019, he has been Vice President of Assolombarda, the association of industrial and service companies operating in Milan and in the provinces of Lodi, Monza and Brianza, with delegated powers over Life Sciences.
Francesca Pasinelle graduated in Pharmacy at the University of Parma and obtained her PHD in Pharmacology from the University of Milan, Dr Francesca Pasinelli was formerly a pharmacologist researcher, before joining Dompé as General Manager of the Q-Rare division for rare diseases research. Since 2009, she has been General Manager of the Telethon Foundation. With a number of awards, including the Merit of the Italian Republic Commander 2007, conferred by the President of the Republic, Dr Francesca Pasinelli is a director of Dompe and sits on the board of directors of a number of academic Institutions and other companies.
Professor Luigi Nicolais graduated in Chemical Engineering from the University of Naples Federico II. He is an engineer and university professor and author of numerous scientific publications. Professor Luigi is one of the most cited Italian scientists in the world and one of the two most cited in material science. From 2012 to 2016, he was President of the National Research Council of Italy (CNR). He has been a professor at a number of Italian universities and visiting professor to many international universities.
He has also been a consultant to Ministries of the Republic and held political roles in the Campania Region. From 2006-2008 he served as Minister for Reforms and Innovation in Public Administration in the XV Legislature and was a member of the Chamber in the XVI Legislature.
Besides his teaching and research activities, Professor Luigi has founded several companies involved in materials and new foods, including as Materias s.r.l., which supports the development of innovative solutions in the advanced materials sector.
He also holds positions with a number of scientific research centers, institutions and foundations.
With a degree in Medical Chemistry from The Sapienza University of Rome, Dr Marcello has been a member of the American Chemical Society since 1988 and the Italian Chemistry Society since 2006.
After a brief period as a university researcher, he joined Dompé as a team leader, before becoming Research Director. He became Chief Scientific Officer in 2009, leading Dompe’s Research and Development work and pre-clinical and clinical drug development programs - from active ingredient identification to market authorization - including relationships with the international regulatory authorities.
He holds a number of university teaching positions and maintains his scientific interests, with published work in over forty scientific journals and over thirty international patents filed.
Flavio Mantelli graduated in Medicine from the Campus Bio-Medico University of Rome, and continued his research in ophthalmology at Harvard Medical School and San Raffaele University Hospital in Milan, collaborating with a number of centers in the USA.
Author of over 70 scientific publications, he is a reviewer for leading international journals in ophthalmology and Adjunct Associate Professor of Biology at Temple University in Philadelphia.
In 2014 he became Dompé US Associate Medical Director, before being appointed Chief Medical Officer of the L’Aquila production plant in 2017.